Report cover image

AI In Genomics Market

Publisher Grand View Research
Published Jan 15, 2026
Length 100 Pages
SKU # GV20873188

Description

AI In Genomics Market Summary

The global AI in genomics market size was valued at USD 1.26 billion in 2025 and is projected to reach USD 18.82 billion by 2033, growing at a CAGR of 40.30% from 2026 to 2033. The growing volume of genomic data, the rising demand for precision medicine, and the acceleration of drug discovery & development are significant factors contributing to market growth.

Moreover, technological advancements and industry partnerships are strengthening the market environment. Rapid advances in next-generation sequencing have significantly increased the volume and complexity of genomic datasets. Whole-genome and multi-omics studies generate data that exceed the capacity of traditional bioinformatics tools. For instance, the National Human Genome Research Institute predicts that genomics research is expected to generate between 2 and 40 exabytes of data within the next decade. However, AI enables scalable processing, interpretation, and integration of these large datasets. The growing intensity of data makes AI essential for genomic research and clinical applications. This structural shift strongly drives AI adoption in genomics.

Moreover, the increasing demand for precision medicine further drives market growth. Genomic insights are crucial for identifying patient-specific disease risks and predicting therapy responses. AI supports the interpretation of complex genotype-phenotype relationships at scale. Precision oncology, rare disease diagnostics, and pharmacogenomics increasingly rely on AI-enabled genomics. In addition, integration with clinical data improves actionable decision-making. For instance, in November 2025, Complete Genomics and SOPHiA GENETICS collaborated at the AMP Annual Meeting to integrate IMSK-IMPACT and MSK-ACCESS, powered by SOPHiA DDM, onto the DNBSEQ-T1+ sequencer, delivering end-to-end, AI-driven cancer genomic profiling.

Global AI in Genomics Market Report Segmentation

This report forecasts, revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented global AI in genomics market report based on component, technology, functionality, application, end use, and region.
  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Hardware
  • Service
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Machine Learning (ML)
  • Deep Learning
  • Supervised Learning
  • Unsupervised Learning
  • Others
  • Computer Vision
  • Functionality Outlook (Revenue, USD Million, 2021 - 2033)
  • Genome Sequencing
  • Gene Editing
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery & Development
  • Precision Medicine
  • Diagnostics
  • Other Applications
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical and Biotech Companies
  • Healthcare Providers
  • Research Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

100 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Scope
1.1.2. Regional Scope
1.1.3. Estimates And Forecast Timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.3.5. Details Of Primary Research
1.4. Information Or Data Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity Flow Analysis (Model 1)
1.6.1.1. Approach 1: Commodity Flow Approach
1.7. Research Assumptions
1.8. List Of Secondary Sources
1.9. List Of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Services outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Cannabis Testing Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Cannabis Testing Services: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Regulatory Framework
3.5. Case Study Analysis
Chapter 4. Cannabis Testing Services Market Segment Analysis, By Service, 2021-2033 (USD Million)
4.1. Definition and Scope
4.2. Services Market Share Analysis, 2025 & 2033
4.3. Segment Dashboard
4.4. Global Cannabis Testing Services Market, By Service, 2021 to 2033
4.5. Potency Testing
4.5.1. Potency Testing Market Estimates And Forecasts, 2021 to 2033 (USD Million)
4.6. Terpene Profiling
4.6.1. Terpene Profiling Market Estimates And Forecasts, 2021 to 2033 (USD Million)
4.7. Heavy Metal Testing
4.7.1. Heavy Metal Testing Market Estimates And Forecasts, 2021 To 2033 (USD Million)
4.8. Pesticide Screening
4.8.1. Pesticide Screening market estimates and forecasts, 2021 to 2033 (USD Million)
4.9. Microscopy Testing
4.9.1. Microscopy Testing Market Estimates And Forecasts, 2021 To 2033 (USD Million)
4.10. Residual Solvent Screening
4.10.1. Residual Solvent Screening Market Estimates And Forecasts, 2021 to 2033 (USD Million)
4.11. Others
4.11.1. Others Market Estimates And Forecasts, 2021 To 2033 (USD Million)
Chapter 5. Cannabis Testing Services Market Segment Analysis, By End Use, 2021-2033 (USD Million)
5.1. Definition And Scope
5.2. End Use Market Share Analysis, 2025 & 2033
5.3. Segment Dashboard
5.4. Global Cannabis Testing Services Market, By End Use, 2021 to 2033
5.5. Cannabis Cultivators/Growers
5.5.1. Cannabis Cultivators/Growers Market Estimates And Forecasts, 2021 to 2033 (USD million)
5.6. Cannabis Drug Manufacturers
5.6.1. Cannabis Drug Manufacturers Market Estimates And Forecasts, 2021 to 2033 (USD Million)
5.7. Others (Research Institutes & Labs)
5.7.1. Others (Research Institutes & Labs) Market Estimates And Forecasts, 2021 to 2033 (USD Million)
Chapter 6. Cannabis Testing Services Market Segment Analysis, By Region, By Service, By End Use, 2021- 2033 (USD Million)
6.1. Regional Market Share Analysis, 2025 & 2033
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Cannabis Testing Services Market Share by Region, 2025 & 2033:
6.5. North America
6.5.1. North America Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.5.2. U.S.
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Scenario
6.5.2.4. U.S. Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.5.3. Canada
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Scenario
6.5.3.4. Canada Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Scenario
6.5.4.4. Mexico Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.6. Europe
6.6.1. Europe Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.6.2. UK
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Scenario
6.6.2.4. UK Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.6.3. Germany
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Scenario
6.6.3.4. Germany Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.6.4. Poland
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Scenario
6.6.4.4. Poland Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.6.5. Italy
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Scenario
6.6.5.4. Italy Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.6.6. Spain
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Scenario
6.6.6.4. Spain Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.6.7. Czech Republic
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Scenario
6.6.7.4. Czech Republic Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.6.8. Switzerland
6.6.8.1. Key Country Dynamics
6.6.8.2. Regulatory Framework
6.6.8.3. Competitive Scenario
6.6.8.4. Switzerland Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.6.9. Croatia
6.6.9.1. Key Country Dynamics
6.6.9.2. Regulatory Framework
6.6.9.3. Competitive Scenario
6.6.9.4. Croatia Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.6.10. Netherlands
6.6.10.1. Key Country Dynamics
6.6.10.2. Regulatory Framework
6.6.10.3. Competitive Scenario
6.6.10.4. Netherlands Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key Country Dynamics
6.7.1.2. Regulatory Framework
6.7.1.3. Competitive Scenario
6.7.1.4. Japan Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.7.2. China
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Scenario
6.7.2.4. China Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.7.3. India
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Scenario
6.7.3.4. India Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.7.4. Australia
6.7.4.1. Key Country Dynamics
6.7.4.2. Regulatory Framework
6.7.4.3. Competitive Scenario
6.7.4.4. Australia Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.7.5. New Zealand
6.7.5.1. Key Country Dynamics
6.7.5.2. Regulatory Framework
6.7.5.3. Competitive Scenario
6.7.5.4. South Korea Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.7.6. Thailand
6.7.6.1. Key Country Dynamics
6.7.6.2. Regulatory Framework
6.7.6.3. Competitive Scenario
6.7.6.4. Thailand Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.8. Latin America and Caribbean
6.8.1. Brazil
6.8.1.1. Key Country Dynamics
6.8.1.2. Regulatory Framework
6.8.1.3. Competitive Scenario
6.8.1.4. Brazil Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.8.2. Uruguay
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Scenario
6.8.2.4. Uruguay Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.8.3. Colombia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Scenario
6.8.3.4. Colombia Cannabis Testing Services Market, 2021 - 2033 (USD Million)
6.9. Africa
6.9.1. Key Country Dynamics
6.9.2. Regulatory Framework
6.9.3. Competitive Scenario
6.9.4. Africa Cannabis Testing Services Market, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Market Position Analysis, 2024/2025 (%)
7.3. Company Categorization
7.4. Company Profiles
7.4.1. Saskatchewan Research Council (SRC)
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. SC Labs
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. SGS Société Générale de Surveillance SA (SGS Canada Inc.)
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Dr. Robert Shrewsbury & the UNC Eshelman School of Pharmacy (PharmLabs)
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. GREEN LEAF LAB
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Eurofins Scientific
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. PhytoVista Laboratories (BRITISH CANNABIS GROUP)
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. BRITISH CANNABIS
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. ADACT Medical Ltd.
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Laboratorium Dr. Liebich
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. AZ Biopharm GmbH
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us